{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:05:34Z","timestamp":1780617934417,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jamda.2025.106093","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:48:37Z","timestamp":1776354517000},"page":"106093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CHROME 2.0 Reduces Psychotropic Prescribing, Improving Neuropsychiatric Symptoms and Falls in People With Dementia"],"prefix":"10.1016","volume":"27","author":[{"given":"Javier","family":"Olazar\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Perea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rigueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"L\u00f3pez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8193-8567","authenticated-orcid":false,"given":"Ruben","family":"Mu\u00f1iz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2025.106093_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40266-023-01020-w","article-title":"Psychotropic medication prescribing to patients with dementia admitted to acute hospitals in Ireland","volume":"40","author":"Timmons","year":"2023","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2025.106093_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.7604","article-title":"Physician antipsychotic overprescribing letters and cognitive, behavioral, and physical health outcomes among people with dementia: a secondary analysis of a randomized clinical trial","volume":"7","author":"Harnisch","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jamda.2025.106093_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S104161021900111X","article-title":"The \"CHROME criteria\": tool to optimize and audit prescription quality of psychotropic medications in institutionalized people with dementia","volume":"32","author":"Mu\u00f1iz","year":"2020","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2025.106093_bib4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/0091270011405665","article-title":"New insights: dose-response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia","volume":"52","author":"Sterke","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2025.106093_bib5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/gps.4483","article-title":"Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults","volume":"32","author":"Johnell","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2025.106093_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1474-4422(08)70295-3","article-title":"The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial","volume":"8","author":"Ballard","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jamda.2025.106093_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JRS-2011-0542","article-title":"Psychiatric drug-induced chronic brain impairment (CBI): implications for long-term treatment with psychiatric medication","volume":"23","author":"Breggin","year":"2011","journal-title":"Int J Risk Saf Med"},{"key":"10.1016\/j.jamda.2025.106093_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/01612840.2025.2476156","article-title":"Examining the long-term impacts of psychotropic drugs and considerations for people discontinuing treatment","volume":"46","author":"Wand","year":"2025","journal-title":"Issues Ment Health Nurs"},{"key":"10.1016\/j.jamda.2025.106093_bib9","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American geriatrics society 2023 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2025.106093_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3","volume":"14","author":"O'Mahony","year":"2023","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.jamda.2025.106093_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2025.106093_bib12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3233\/ADR-210015","article-title":"CHROME criteria and quality of life: a pilot study from maria Wolff-Albertia","volume":"5","author":"Mu\u00f1iz","year":"2021","journal-title":"J Alzheimers Dis Rep"},{"key":"10.1016\/j.jamda.2025.106093_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1176\/appi.ajp.2015.15010130","volume":"173","author":"Ballard","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2025.106093_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S2215-0366(19)30045-8","article-title":"Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial","volume":"6","author":"Livingston","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jamda.2025.106093_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000316119","article-title":"Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy","volume":"30","author":"Olazar\u00e1n","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jamda.2025.106093_bib16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1192\/bjp.bp.113.141119","article-title":"Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials","volume":"205","author":"Livingston","year":"2014","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jamda.2025.106093_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014177","article-title":"Systematic review of the effective components of psychosocial interventions delivered by care home staff to people with dementia","volume":"7","author":"Rapaport","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jamda.2025.106093_bib18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2025.106093_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\": a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jamda.2025.106093_bib20","first-page":"653","article-title":"Functional assessment staging (FAST)","volume":"24","author":"Reisberg","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.jamda.2025.106093_bib21","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2025.106093_bib22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3233\/JAD-215133","article-title":"Clinical trajectories of neuropsychiatric symptoms in mild-moderate to advanced dementia","volume":"86","author":"Castillo-Garc\u00eda","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jamda.2025.106093_bib23","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jamda.2014.06.012","article-title":"Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review","volume":"15","author":"Thompson Coon","year":"2014","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2025.106093_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002500","article-title":"Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: a cluster-randomised controlled trial","volume":"15","author":"Ballard","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.jamda.2025.106093_bib25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jamda.2018.05.002","article-title":"Antipsychotic deprescription for older adults in long-term care: the HALT study","volume":"19","author":"Brodaty","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2025.106093_bib26","first-page":"CD007726","article-title":"Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia","volume":"1","author":"Leeuwen","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2025.106093_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/gps.1895","article-title":"Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription","volume":"23","author":"Benoit","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2025.106093_bib28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3233\/JAD-2012-120913","article-title":"Apathy syndrome in Alzheimer's disease epidemiology: prevalence, incidence, persistence, and risk and mortality factors","volume":"33","author":"Vilalta-Franch","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jamda.2025.106093_bib29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jamda.2016.04.006","article-title":"Apathy and its response to antipsychotic review and nonpharmacological interventions in people with dementia living in nursing homes: WHELD, a factorial cluster randomized controlled trial","volume":"17","author":"Rajkumar","year":"2016","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2025.106093_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40266-025-01189-2","article-title":"Medicine optimisation and deprescribing intervention outcomes for older people with dementia or mild cognitive impairment: a systematic review","volume":"42","author":"Andrews","year":"2025","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2025.106093_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12877-018-1015-9","article-title":"Consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients","volume":"19","author":"Massot Mesquida","year":"2019","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jamda.2025.106093_bib32","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jamda.2021.12.031","article-title":"Optimizing Practices, Use, care, and Services-Antipsychotics (OPUS-AP) in long-term care centers in Quebec, Canada: a successful scale-up","volume":"23","author":"Cossette","year":"2022","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2025.106093_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1017\/S1041610220000629","article-title":"Can the PROPER intervention reduce psychotropic drug prescription in nursing home residents with dementia? Results of a cluster-randomized controlled trial","volume":"33","author":"Smeets","year":"2021","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2025.106093_bib34","doi-asserted-by":"crossref","first-page":"276.e1","DOI":"10.1016\/j.jamda.2017.12.100","article-title":"Effects of psychosocial interventions for behavioral and psychological symptoms in dementia on the prescription of psychotropic drugs: a systematic review and meta-analyses","volume":"19","author":"Birkenh\u00e4ger-Gillesse","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2025.106093_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40266-018-0518-6","article-title":"Clinical and economic outcomes of interventions to reduce antipsychotic and benzodiazepine use within nursing homes: a systematic review","volume":"35","author":"Hoyle","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2025.106093_bib36","article-title":"Psychosocial interventions for reducing antipsychotic medication in care home residents","volume":"8","author":"L\u00fchnen","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2025.106093_bib37","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1017\/S1041610220000940","article-title":"Clinical impact of antipsychotic and benzodiazepine reduction: findings from a multicomponent psychotropic reduction program within long-term aged care","volume":"33","author":"Hoyle","year":"2021","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2025.106093_bib38","doi-asserted-by":"crossref","first-page":"531.e1","DOI":"10.1016\/j.jamda.2014.04.007","article-title":"Coming to grips with challenging behavior: a cluster randomized controlled trial on the effects of a multidisciplinary care program for challenging behavior in dementia","volume":"15","author":"Zwijsen","year":"2014","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2025.106093_bib39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.5694\/mja17.00857","article-title":"RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities","volume":"208","author":"Westbury","year":"2018","journal-title":"Med J Aust"},{"key":"10.1016\/j.jamda.2025.106093_bib40","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/gps.5167","article-title":"Why deprescribing antipsychotics in older people with dementia in long-term care is not always successful: insights from the HALT study","volume":"34","author":"Aerts","year":"2019","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2025.106093_bib41","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jagp.2015.07.001","article-title":"Trends in psychotropic dispensing among older adults with dementia living in long-term care facilities: 2004-2013","volume":"23","author":"Vasudev","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2025.106093_bib42","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1017\/S1041610211000755","article-title":"Prescribing pattern of psychotropic drugs in nursing home residents with dementia","volume":"23","author":"Wetzels","year":"2011","journal-title":"Int Psychogeriatr"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861025006103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861025006103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:57:01Z","timestamp":1780617421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861025006103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1525861025006103"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2025.106093","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CHROME 2.0 Reduces Psychotropic Prescribing, Improving Neuropsychiatric Symptoms and Falls in People With Dementia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2025.106093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"106093"}}